Global Bioenergies SA
GLLBF
OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 100.53% | 100.55% | -89.20% | -88.94% | -1,088.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 100.53% | 100.55% | -89.20% | -88.94% | -1,088.09% |
| Cost of Revenue | 126.47% | 127.00% | -88.52% | -88.25% | 41.79% |
| Gross Profit | 81.72% | 81.35% | 80.68% | 80.26% | -190.84% |
| SG&A Expenses | -62.04% | -61.27% | -19.94% | -18.04% | -24.01% |
| Depreciation & Amortization | -82.08% | -81.72% | 15.14% | 17.87% | 61.69% |
| Other Operating Expenses | 99.32% | 99.31% | -0.18% | -2.55% | -253.83% |
| Total Operating Expenses | 126.07% | 130.60% | -54.62% | -53.55% | -75.37% |
| Operating Income | 33.94% | 32.61% | 27.39% | 25.67% | 20.15% |
| Income Before Tax | 25.68% | 24.19% | 32.47% | 30.87% | 20.93% |
| Income Tax Expenses | -4.37% | -6.47% | -- | -- | 13.58% |
| Earnings from Continuing Operations | 33.48% | 32.15% | 32.47% | 30.87% | 22.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.48% | 32.15% | 32.47% | 30.87% | 22.63% |
| EBIT | 33.94% | 32.61% | 27.39% | 25.67% | 20.15% |
| EBITDA | 33.10% | 31.75% | 73.74% | 73.11% | 25.99% |
| EPS Basic | 33.19% | 31.83% | 35.54% | 33.98% | 36.02% |
| Normalized Basic EPS | 30.68% | 29.31% | 33.73% | 32.21% | 35.49% |
| EPS Diluted | 33.19% | 31.83% | 35.54% | 33.98% | 36.02% |
| Normalized Diluted EPS | 30.68% | 29.31% | 33.73% | 32.21% | 35.49% |
| Average Basic Shares Outstanding | -0.45% | -0.45% | 4.71% | 4.71% | 20.98% |
| Average Diluted Shares Outstanding | -0.45% | -0.45% | 4.71% | 4.71% | 20.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |